South Korea Allergy Immunotherapy Market Insight
Published: 04 June 2026 | Report Format: Electronic (PDF)
The South Korea allergy immunotherapy market will grow at a rate of 8.08% due to increasing allergy prevalence, rising awareness regarding immunotherapy treatments, technological advancements in allergy diagnostics, and expanding adoption of personalized healthcare solutions.
South Korea Allergy Immunotherapy Market Insights Forecasts to 2035
- The South Korea Allergy Immunotherapy Market Size Was Estimated USD 214.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.08% from 2025 to 2035
- The South Korea Allergy Immunotherapy Market Size is Expected to rise around USD 466.9 Million by 2035
Notable Insights for the South Korea Allergy Immunotherapy Market
- Segmentation on the basis of Treatment Type indicates that Subcutaneous Immunotherapy segment holds dominant position in the South Korea Allergy Immunotherapy Market in 2025 with market share of nearly 56% because of higher effectiveness, patient adoption.
- Segmentation on the basis of Allergen Type indicates that respiratory allergies segment dominates the South Korea Allergy Immunotherapy Market during 2025 market share of around 59% because of increasing pollution and seasonal allergies.
- World-wide projected revenue of stallergenes greer in fiscal year 2025 would be around $420 million owing to growing demand for allergy immunotherapy products, respiratory treatments, and personalized healthcare solutions globally.
- It is expected that increasing healthcare awareness and advanced allergy treatments would support market growth, where immunotherapy solutions improve allergy control up to 41% and reduce recurrence risks nearly 29% .
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in allergy treatment technologies, respiratory healthcare awareness, and immunotherapy developments on the South Korea Allergy Immunotherapy Market growth.
- Provides strategic insights regarding technology innovation such as biologics-based immunotherapy, personalized allergy treatment solutions, AI-based diagnostics, and advanced respiratory monitoring technologies.
- Assists players to analyze competitive benchmarking, healthcare investments, treatment innovations, and expansion strategies by major allergy immunotherapy providers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Allergy Immunotherapy Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Allergy Immunotherapy Market
-
- Stallergenes Greer
- ALK-Abelló A/S
- HAL Allergy Group
- Allergy Therapeutics plc
- Merck KGaA
- Circassia Group plc
- Biomay AG
- HollisterStier Allergy
- Torii Pharmaceutical Co., Ltd.
- Aimmune Therapeutics
Recent Developments:
- In September 2025, ALK-Abelló A/S introduced advanced sublingual immunotherapy tablets designed for respiratory allergy management and improved patient convenience in South Korea.
- In June 2025, Stallergenes Greer expanded its allergy diagnostic and immunotherapy product portfolio focusing on personalized respiratory allergy treatment technologies.
Market Segmentation:
South Korea Allergy Immunotherapy Market, By Treatment Type
-
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- Combination Immunotherapy
- Allergy Vaccines
- Biologics-Based Immunotherapy
South Korea Allergy Immunotherapy Market, By Allergen Type
-
- Respiratory Allergies
- Food Allergies
- Skin Allergies
- Insect Venom Allergies
- Others
South Korea Allergy Immunotherapy Market, By Application
-
- Hospitals
- Specialty Clinics
- Research Institutions
- Homecare Settings
- Diagnostic Centers
Expert Views:
The market for allergy immunotherapy in South Korea will grow owing to increasing respiratory allergies, rising healthcare awareness, and growing adoption of advanced immunotherapy treatments. The inclusion of personalized immunotherapy solutions, biologics-based allergy treatments, and artificial intelligence enabled diagnostic technologies will improve treatment efficiency and support the demand for allergy immunotherapy products in the South Korean market.
Author: Komal and Pranali By Spherical Insights and Consulting